Search

Search Constraints

You searched for: Author/Creator Rodriguez, M. Alma

Search Results

1. Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma. (5th July 2016)

2. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma. (28th February 2019)

3. Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma. Issue 20 (28th June 2016)

4. Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low‐grade B‐cell lymphomas. (31st March 2015)

5. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Issue 12 (3rd May 2018)

6. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T‐cell lymphoma. (10th August 2015)

7. The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma. (16th December 2016)